Significant readouts for small players
Praxis and Relmada target depression as Athira and Taurx tackle Alzheimer’s.
Key data reveals for the small players
Praxis, Proqr and Nordic Nanovector are awaiting important data.
Vertex finally catches a break
The group gets a long-awaited win in kidney disease, but sales potential is hard to call.
Biopharma takeovers show quantity, if not quality
Second-quarter deal values plummeted as Covid-19 spread and the prices of target companies spiralled.
Chinook marks an ignominious end for Sting
Aduro finally runs up the white flag on Sting agonism, and becomes a listed shell for Chinook Therapeutics.
